awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39266678-24C00F29-5C5C-4BE7-A6DC-662D3BEF14CB
Q39266678-24C00F29-5C5C-4BE7-A6DC-662D3BEF14CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39266678-24C00F29-5C5C-4BE7-A6DC-662D3BEF14CB
Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis.
P2860
Q39266678-24C00F29-5C5C-4BE7-A6DC-662D3BEF14CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39266678-24C00F29-5C5C-4BE7-A6DC-662D3BEF14CB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ffff43bdb97dfec2f47d7bc8bd5e78feb541841c
P2860
Omarigliptin: first global approval.